Direct-to-consumer (DTC) genetic testing is genetic tests or services, which directly advertised to consumers and purchased through consumers’ requests. The DTC genetic testing market contains two business models: one-to-one and one-to-many. The key companies operating in this market gain profit from the sales of DTC genetic testing kits to consumers and physicians and the sales of genetic data to pharmaceutical companies. This major factor is expected to boost the growth of the DTC genetic testing market.
Furthermore, factors such as the increasing old age population across the globe and increasing prevalence of chronic disorders such as cardiovascular diseases (CVDs), type 2 diabetes, diabetic retinopathy, and other chronic diseases are contributing more to the market’s growth. Moreover, increasing customer awareness about direct-to-consumer genetic testing as well as the growing prevalence of major chronic diseases has resulted in rising healthcare expenditure and the high demand for DTC genetic testing is an increase for early diagnosis of various diseases. These important factors will remarkably be contributing to the growth of the direct-to-consumer genetic testing market in the coming years.
On the downside, DTC genetic testing raises several issues such as scientific, technical, and clinical issues, along with First Amendment issues of honesty, fidelity to facts, and truth-in-advertising, are hampering the growth of the market.
Covid-19 Impact on Direct-To-Consumer (DTC) Genetic Testing Market:
In addition, the current Direct-To-Consumer (DTC) Genetic Testing Market study offers a detailed analysis of the current COVID-19 pandemic impact on the market growth and its influence on the future growth of the Direct-To-Consumer (DTC) Genetic Testing Market. The recently published report demonstrates the elevation in the demand for the healthcare sector. The healthcare manufacturers have experienced long term as well as short term effect which includes supply shortages, panic buying, and stocking, regulation changes as short-term whereas approval delays and possible trend variations in consumption could be perceived as long-term impacts of COVID-19 on the health and pharmaceutical market.
The increasing need for a cure has pushed vaccine research and manufacturers to the limit. In addition to this, panic conditions have already spurred the demand for many healthcare products and services which are discussed in detail in this report. Moreover, the impact of COVID-19 on overall market revenue for the base year 2020 and its projection up to 2027 is provided in detail in this report.
Direct-To-Consumer (DTC) Genetic Testing Market Segment Overview
Based on service, the Diagnostic Screening segment has significant growth in the global Direct-To-Consumer (DTC) Genetic Testing market. This is because it helps in identifying the gene responsible for chronic diseases such as cancer. This includes carrier screening and hereditary testing that are generally conducted for DTC genetic testing. According to the distribution channel, the direct sales segment generates high revenue due to pricing strategies.
Direct-To-Consumer (DTC) Genetic Testing Market, By Service
· Diagnostic Screening
· Prenatal
· Newborn Screening
· Pre-Implantation Diagnosis
· Relationship Testing
Direct-To-Consumer (DTC) Genetic Testing Market, By Distribution Channel
· Direct Sales
· Retail Sales
· Laboratory Sales
Direct-To-Consumer (DTC) Genetic Testing Market Regional Overview
In terms of region, North America dominated the global DTC genetic testing market. This can be attributed to the importance of early diagnosis for better treatment outcomes, and a high level of consumer literacy about diseases. Similarly, Asia Pacific is expected to be the most prominent market during the forecast period. This is because of rising health care awareness and growing disposable income in this region.
Direct-To-Consumer (DTC) Genetic Testing Market, By Geography
· North America (US & Canada)
· Europe (UK, Germany, France, Italy, Spain, Russia & Rest of Europe)
· Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific)
· LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)
Direct-To-Consumer (DTC) Genetic Testing Market, Key Players
· 23andMe, Inc.
· Laboratory Corporation of America
· Myriad Genetics, Inc.
· Quest Diagnostics
· Counsyl, Inc.
· Gene by Gene
· Positive Bioscience Ltd.
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
4. Key Insights
- 4.1. Key Emerging Trends – For Major Countries
- 4.2. Latest Technological Advancement
- 4.3. Regulatory Landscape
- 4.4. Industry SWOT Analysis
- 4.5. Porters Five Forces Analysis
5. Global Direct-To-Consumer (DTC) Genetic Testing Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 5.1. Key Findings / Summary
- 5.2. Market Analysis, Insights and Forecast – By Service
- 5.2.1. Diagnostic Screening
- 5.2.2. Prenatal
- 5.2.3. Newborn Screening
- 5.2.4. Pre-Implantation Diagnosis
- 5.2.5. Relationship Testing
- 5.3. Market Analysis, Insights and Forecast – By Distribution Channel
- 5.3.1. Direct Sales
- 5.3.2. Retail Sales
- 5.3.3. Laboratory Sales
- 5.4. Market Analysis, Insights and Forecast – By Region
- 5.4.1. North America
- 5.4.2. Europe
- 5.4.3. Asia Pacific
- 5.4.4. Latin America, Middle East and Africa
6. North America Direct-To-Consumer (DTC) Genetic Testing Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 6.1. Key Findings / Summary
- 6.2. Market Analysis, Insights and Forecast – By Service
- 6.2.1. Diagnostic Screening
- 6.2.2. Prenatal
- 6.2.3. Newborn Screening
- 6.2.4. Pre-Implantation Diagnosis
- 6.2.5. Relationship Testing
- 6.3. Market Analysis, Insights and Forecast – By Distribution Channel
- 6.3.1. Direct Sales
- 6.3.2. Retail Sales
- 6.3.3. Laboratory Sales
- 6.4. Market Analysis, Insights and Forecast – By Country
- 6.4.1. U.S.
- 6.4.2. Canada
7. Europe Direct-To-Consumer (DTC) Genetic Testing Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 7.1. Key Findings / Summary
- 7.2. Market Analysis, Insights and Forecast – By Service
- 7.2.1. Diagnostic Screening
- 7.2.2. Prenatal
- 7.2.3. Newborn Screening
- 7.2.4. Pre-Implantation Diagnosis
- 7.2.5. Relationship Testing
- 7.3. Market Analysis, Insights and Forecast – By Distribution Channel
- 7.3.1. Direct Sales
- 7.3.2. Retail Sales
- 7.3.3. Laboratory Sales
- 7.4. Market Analysis, Insights and Forecast – By Country
- 7.4.1. UK
- 7.4.2. Germany
- 7.4.3. France
- 7.4.4. Italy
- 7.4.5. Spain
- 7.4.6. Russia
- 7.4.7. Rest of Europe
8. Asia Pacific Direct-To-Consumer (DTC) Genetic Testing Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 8.1. Key Findings / Summary
- 8.2. Market Analysis, Insights and Forecast – By Service
- 8.2.1. Diagnostic Screening
- 8.2.2. Prenatal
- 8.2.3. Newborn Screening
- 8.2.4. Pre-Implantation Diagnosis
- 8.2.5. Relationship Testing
- 8.3. Market Analysis, Insights and Forecast – By Distribution Channel
- 8.3.1. Direct Sales
- 8.3.2. Retail Sales
- 8.3.3. Laboratory Sales
- 8.4. Market Analysis, Insights and Forecast – By Country
- 8.4.1. China
- 8.4.2. India
- 8.4.3. Japan
- 8.4.4. Australia
- 8.4.5. South East Asia
- 8.4.6. Rest of Asia Pacific
9. Latin America, Middle East and Africa Direct-To-Consumer (DTC) Genetic Testing Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 9.1. Key Findings / Summary
- 9.2. Market Analysis, Insights and Forecast – By Service
- 9.2.1. Diagnostic Screening
- 9.2.2. Prenatal
- 9.2.3. Newborn Screening
- 9.2.4. Pre-Implantation Diagnosis
- 9.2.5. Relationship Testing
- 9.3. Market Analysis, Insights and Forecast – By Distribution Channel
- 9.3.1. Direct Sales
- 9.3.2. Retail Sales
- 9.3.3. Laboratory Sales
- 9.4. Market Analysis, Insights and Forecast – By Country
- 9.4.1. Brazil
- 9.4.2. Saudi Arabia
- 9.4.3. UAE
- 9.4.4. Rest of LAMEA
10. Competitive Analysis
- 10.1. Company Market Share Analysis, 2018
- 10.2. Key Industry Developments
- 10.3. Company Profile
- 10.4. 23andMe, Inc.
- 10.4.1. Business Overview
- 10.4.2. Segment 1 & Service Offering
- 10.4.3. Overall Revenue
- 10.4.4. Geographic Presence
- 10.4.5. Recent Development
- 10.5. Laboratory Corporation of America
- 10.6. Myriad Genetics, Inc.
- 10.7. Quest Diagnostics
- 10.8. Counsyl, Inc.
- 10.9. Gene by Gene
Data Library Research are conducted by industry experts who offer insight on industry structure, market segmentations technology assessment and competitive landscape (CL), and penetration, as well as on emerging trends. Their analysis is based on primary interviews (~ 80%) and secondary research (~ 20%) as well as years of professional expertise in their respective industries. Adding to this, by analysing historical trends and current market positions, our analysts predict where the market will be headed for the next five years. Furthermore, the varying trends of segment & categories geographically presented are also studied and the estimated based on the primary & secondary research.
In this particular report from the supply side Data Library Research has conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and SOFT) of the companies that active & prominent as well as the midsized organization
FIGURE 1: DLR RESEARH PROCESSPrimary Research
Extensive primary research was conducted to gain a deeper insight of the market and industry performance. The analysis is based on both primary and secondary research as well as years of professional expertise in the respective industries.
In addition to analysing current and historical trends, our analysts predict where the market is headed over the next five years.
It varies by segment for these categories geographically presented in the list of market tables. Speaking about this particular report we have conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and many more) of the major players active in the market.
Secondary ResearchSecondary research was mainly used to collect and identify information useful for the extensive, technical, market-oriented, and Friend’s study of the Global Extra Neutral Alcohol. It was also used to obtain key information about major players, market classification and segmentation according to the industry trends, geographical markets, and developments related to the market and technology perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, sec filings, journals, white papers, SOFT presentations, and company web sites.
Market Size EstimationBoth, top-down and bottom-up approaches were used to estimate and validate the size of the Global market and to estimate the size of various other dependent submarkets in the overall Extra Neutral Alcohol. The key players in the market were identified through secondary research and their market contributions in the respective geographies were determined through primary and secondary research.
Forecast Model